Tandem Investment Advisors Inc. Takes $217,000 Position in Revvity, Inc. (NYSE:RVTY)

Tandem Investment Advisors Inc. acquired a new stake in shares of Revvity, Inc. (NYSE:RVTY) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 1,983 shares of the company’s stock, valued at approximately $217,000.

Several other large investors also recently made changes to their positions in RVTY. Gladius Capital Management LP lifted its position in shares of Revvity by 84.1% in the third quarter. Gladius Capital Management LP now owns 232 shares of the company’s stock worth $26,000 after purchasing an additional 106 shares in the last quarter. CENTRAL TRUST Co purchased a new stake in shares of Revvity in the fourth quarter worth approximately $27,000. ORG Partners LLC purchased a new stake in shares of Revvity in the fourth quarter worth approximately $32,000. JTC Employer Solutions Trustee Ltd purchased a new stake in shares of Revvity in the fourth quarter worth approximately $33,000. Finally, Desjardins Global Asset Management Inc. purchased a new stake in shares of Revvity in the fourth quarter worth approximately $37,000. Institutional investors own 86.65% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Barclays increased their price target on shares of Revvity from $92.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 25th. UBS Group downgraded Revvity from a “buy” rating to a “neutral” rating and increased their price objective for the stock from $105.00 to $125.00 in a report on Tuesday, January 16th. Wells Fargo & Company started coverage on Revvity in a report on Tuesday, December 19th. They issued an “equal weight” rating and a $95.00 price objective on the stock. Evercore ISI upgraded Revvity from an “in-line” rating to an “outperform” rating and increased their price target for the company from $88.00 to $125.00 in a report on Thursday, January 4th. Finally, Raymond James increased their price target on Revvity from $106.00 to $127.00 and gave the company an “outperform” rating in a report on Friday, February 2nd. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $118.91.

Insider Buying and Selling

In other Revvity news, insider Prahlad R. Singh sold 21,217 shares of Revvity stock in a transaction on Monday, February 5th. The stock was sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the completion of the transaction, the insider now directly owns 92,801 shares of the company’s stock, valued at $9,677,288.28. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.60% of the stock is owned by company insiders.

Revvity Stock Performance

Shares of Revvity stock traded up $0.26 during midday trading on Wednesday, hitting $100.54. The company had a trading volume of 773,236 shares, compared to its average volume of 861,356. The business’s 50 day simple moving average is $104.96 and its two-hundred day simple moving average is $101.71. The stock has a market cap of $12.42 billion, a PE ratio of 18.23, a P/E/G ratio of 2.66 and a beta of 1.09. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.07 and a quick ratio of 1.77. Revvity, Inc. has a 1-year low of $79.50 and a 1-year high of $136.89.

Revvity (NYSE:RVTY) last issued its earnings results on Thursday, February 1st. The company reported $1.25 EPS for the quarter, topping the consensus estimate of $1.15 by $0.10. The firm had revenue of $695.90 million during the quarter. Revvity had a return on equity of 7.41% and a net margin of 25.20%. As a group, equities analysts predict that Revvity, Inc. will post 4.65 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Friday, April 19th will be given a $0.07 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.28 annualized dividend and a yield of 0.28%. Revvity’s dividend payout ratio (DPR) is currently 5.09%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.